Primary cutaneous melanoma: An 18-year study

Clinics

Volumn 65, Issue 3, 2010, Pages 257-263

  Anger, Moris ^a   Friedhofer, Henri ^b   Fukutaki, Marina Fussae ^a   Ferreira, Marcus Castro ^b   Landman, Gilles ^c  

^a Brigadeiro Hospital   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Epidemiology; Melanoma; Prognosis; Risk factors; Skin neoplasm

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MELANOMA; MIDDLE AGED; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; RADIATION INDUCED NEOPLASM; RETROSPECTIVE STUDY; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77953496608     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000300004     Document Type: Article

References (36)

1. Wainstein AJA, Belfort FA. Conduta para o melanoma cutâneo. Ver Col Bras Cir. 2004; 31:204-14.
2. st century: The emerging molecular landscape. Mayo Clin Proc. 2008; 83:825-46.
3. Tomatis L. Cancer: Causes, occurrence and control. IARC Scientific Publication. 1990; 368:100.
4. Azevedo G, Mendonça S. Risco crescente de melanoma de pele no Brasil. Rev Saude Publica. 1992;26:290-4.
5. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48.
6. Benett DC. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003;22:3063-9.
7. Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, et al. Annual report to the nation on the status of cancer (1973 through 198), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-42.
8. INCA - Instituto Nacional de Câncer. Câncer de pele: Melanoma. Disponível em: www.inca.gov.br. Acesso em: 12 de agosto de 2008.
9. Essner R. Surgical treatment of malignant melanoma. Surg Clin N Am. 2003;83:109-56.
10. Clark Jr. WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705-27.
11. Breslow A, Macht SD. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet 1977;145:691-2.
12. Elder DE, Guerry D 4th, Heiberger RM, LaRossa D, Goldman LI, Clark WH Jr, et al. Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg. 1983; 71:66-72.
13. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, et al. Incidence of and survival from malignant melanoma in Scotland: An epidemiological study. Lancet. 2002; 360:587-91.
14. Alonso SR, Otiz P, Pollán M, Pérez-Gomez B, Sánchez L, Acuña MJ, et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: A tissue microarray-based study. Am J Pathol. 2004;164:193-203.
15. Lapa MS, Guedes KF, Schach FO, Landman G. Melanomas cutâneos tratados no Hospital do Câncer em São Paulo. Estudo retrospectivo para avaliação de distribuição, fatores prognósticos e sobrevida. An Bras Dermatol. 2002;77:313-20.
16. Kuo TC, Hoon DSB, Takeuchi H, Turner R, Wang He-Jing, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol. 2003;19:3566-72.
17. Baldi A, Santini D, De Luca A, Paggi MG. cDNA array technology in melanoma: An overview. J Cell Physiol. 2003;196:219-23.
18. Bar-Eli M. Molecular mechanisms of melanoma metastasis. J Cell Physiol. 1997; 173:275-8.
19. Welch DR, Goldberg SF. Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology. 1997;65:311-30.
20. Landman G, Muller H, Neto JF, Maceira JMP, Costa M, Costa MB, et al. Consenso para o laudo anatomopatológico do melanoma cutâneo. Acta Oncol Brasil. 2003;23:504-10.
21. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Norwalk: Appleton & Lange; 1994.
22. Tamir G, Milo Y, Rothem A, Sulkes J, Hauben DJ. Cutaneous malignant melanoma in young adults under age 30. Isr J Med Sci. 1996;32:1290-6.
23. Criado PR, Vasconcelos C, Sittart JAS, Valente NYS, Moura BPS, Barbosa GL, et al. Melanoma maligno cutâneo primário: Estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. Rev Ass Méd Brasil. 1999;45:157-62.
24. Ferrari Júnior NM, Muller H, Ribeiro M, Maia M, Sanches Júnior JA. Cutaneous melanoma: descriptive epidemiological study. Sao Paulo Med J. 2008;126:41-7.
25. Sortino-Rachou AM, Curado MP, Latorre MRDO. Melanoma cutâneo: estudo de base populacional em Goiânia, Brasil, 1988 - 2000. An Bras Dermatol. 2006;81:449-55.
26. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: Data from the 1973 through 1994 surveillance, epidemiology, and end Results program registry. Arch Dermatol. 1999;135:275-80.
27. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-83.
28. MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992; 84:1427-32.
29. Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 2002;41:138-46.
30. Marrett LD, Nguyen HL, Armstrong BK. Recent trends in the incidence of malignant melanoma in New South Wales 1983-1996. Int J Cancer. 2001;92:457-62.
31. Ohtsuka H, Nagamatsu S. Changing trends in numbers of deaths from Malignant Melanoma in Japan, 1955-2000. Dermatology. 2003;207:162-5.
32. Carmichael VE, Wilson KS. Primary cutaneous malignant melanoma: Experience of British Columbia Cancer Agency from 1972 to 1981. CJS. 1992;35:589-97.
33. Tovo LFR, Belfort FA, Sanches Jr JA. Melanoma cutâneo primário. Rev Assoc Med Bras. 2005;51:1-10.
34. Holme SA, Malinovsky K, Roberts DL. Malignant melanoma in South Wales: Changing trends in presentation (1986-1998). Clin Exp Dermatol. 2001;26:484-9.
35. Oumeish OU. Epidemiology of primary cutaneous malignant melanoma in Jordan. Intern J Dermatol. 1995;36:113-5.
36. Borges SZ, Bakos L, Cartell A, Wagner M, Agostini A, Lersch E. Int J Dermatol. 2007; 46:679-86.